[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626573":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":36,"locations":44,"responsibleParty":65,"collaborators":24,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":24,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":24,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":24,"overallStatus":47,"whyStopped":24,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"RESnTEC, Institute of Research","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"L-carnitine Group","EXPERIMENTAL","Patients will receive L-carnitine at a therapeutic dosage of 30 mg\u002Fkg\u002Fday, in conjunction with a standard care regimen comprising a total dosage of 100 mg phospholipids\u002Fkg birth weight (4 ml\u002Fkg), divided into four quarter-dose aliquots.",[13,14],"Drug: L-carnitine","Drug: Standard care",{"label":16,"type":10,"description":17,"interventionNames":18},"No L-carnitine Group","Patients will get only a standard care regimen comprising a total dosage of 100 mg phospholipids\u002Fkg birth weight (4 ml\u002Fkg), divided into four quarter-dose aliquots.",[14],[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG","L-carnitine",[9],null,{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Standard care","Patients will get a standard care regimen comprising a total dosage of 100 mg phospholipids\u002Fkg birth weight (4 ml\u002Fkg), divided into four quarter-dose aliquots.",[9,16],[30,34],{"name":31,"affiliation":32,"role":33},"Muhammad Sarfraz, FCPS","Recep Tayyip Erdogan Hospital, Muzaffargarh","PRINCIPAL_INVESTIGATOR",{"name":35,"affiliation":32,"role":33},"Athar Razzaq, FCPS",[37,41],{"name":31,"role":38,"phone":39,"phoneExt":24,"email":40},"CONTACT","+923336464238","drfraz1986@gmail.com",{"name":35,"role":38,"phone":42,"phoneExt":24,"email":43},"+923007183545","athar.razzaq@tih.org.pk",[45],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Recep Tayyip Erdogan Hospital\u002FIndus Hospital & Health Network","RECRUITING","Muzaffargarh","Punjab Province","32400","Pakistan","PK",{"type":54,"coordinates":55},"Point",[56,57],71.19379,30.07258,{"lat":57,"lon":56},[60,61,63,64],{"name":31,"role":38,"phone":39,"phoneExt":24,"email":40},{"name":62,"role":38,"phone":42,"phoneExt":24,"email":43},"Athar Razzaq, PCPS",{"name":31,"role":33,"phone":24,"phoneExt":24,"email":24},{"name":35,"role":33,"phone":24,"phoneExt":24,"email":24},{"type":66,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"SPONSOR_INVESTIGATOR","Muhammad Aamir Latif","Research Consultant","100626573","effect-of-l-carnitine-supplementation-in-preterm-neonates-100626573",false,"NCT07437391","Effect of L-Carnitine Supplementation in Preterm Neonates","Effect of L-Carnitine Supplementation in Preterm Neonates Suffering From Respiratory Distress Syndrome (RDS)","Inclusion Criteria:\n\n* Preterm neonates\n* Either gender\n* With RDS\n* Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth .\n\nExclusion Criteria:\n\n* Neonates with gastrointestinal tract (GIT) anomalies\n* With confirmed or suspected sepsis at the time of enrollment\n* Neonates whose clinical condition contraindicates study participation (e.g., expected survival \\\u003C48 hours, as judged by the neonatologist).","ALL","1 Hour","24 Hours",{"count":80,"type":81},160,"ESTIMATED","INTERVENTIONAL",[84],"NA","The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.",[87],"Respiratory Distress Syndrome","2026-02-23",{"date":90,"type":91},"2026-02-27","ACTUAL",{"date":93,"type":91},"2026-01-01",{"date":95,"type":81},"2026-06-30",{"name":67,"class":6},1]